chartexchange

MGTX
MeiraGTx Holdings plc
stockNASDAQ

Market OpenNov 19, 2026 2:59:18 PM EST
8.14USD-2.163%(-0.18)353,759
8.1300Bid8.1500Ask0.0200Spread
Loading…
Loading…
796.50M
Healthcare
Biotechnology
HQ
New York, NY, USA
Previous Close
$8.32
Beta
1.67
52-Week High
$15.35 2026-07-07
52-Week Low
$6.62 2026-03-05
SMA 50
$10.41
SMA 200
$10.39
Avg. Vol 10D
737,663
Avg. Vol 30D
690,446
Avg. Vol 90D
742,786
Relative Vol
0.51
74.92M
0.3900%
1,800,000
MGTX Profile

meiragtx, a london and new york-based gene therapy company, is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. we are pioneering the use of gene therapy to treat devastating neurodegenerative diseases such as alzheimer's disease (ad), parkinson's disease (pd), and amyotrophic lateral sclerosis (als). we are developing innovative gene therapies for ocular diseases including rare inherited blindness and age-related macular degeneration (amd). meiragtx is also establishing treatments for xerostomia, a frequent and debilitating side effect of radiation treatment used in head and neck cancers. our revolutionary gene regulation technologies promise to transform the way gene therapy can be applied and create new paradigms for biologic therapeutics.

MGTX Performance
PeriodPriceDateChangeBeta
1W8.792026-11-12-7.28%3.947
1M9.452026-10-19-13.76%2.017
3M14.972026-08-19-45.56%1.760
6M9.132026-05-19-10.73%1.493
1Y7.582025-11-19+7.52%1.672
2Y5.982024-11-19+36.29%—
5Y18.652021-11-19-56.30%1.253
MGTX Stock Summary

MeiraGTx Holdings plc (NASDAQ:MGTX) stock price today is $8.15, and today's volume is 353,150. MGTX is down 2.043% today. The 30 day average volume is 690,446. MGTX market cap is $796.50M with 97.73M shares outstanding.